Production (Stage)
MEI Pharma, Inc.
MEIP
$2.18
$0.03081.43%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -63.80% | -60.09% | -67.27% | -61.92% | -49.52% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -95.70% | -- | -- | -77.17% | -27.23% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -36.12% | -- |
Total Current Assets | -65.00% | -63.15% | -68.62% | -62.09% | -50.73% |
|
|||||
Total Current Assets | -65.00% | -63.15% | -68.62% | -62.09% | -50.73% |
Net Property, Plant & Equipment | -- | -- | -99.96% | -95.44% | -13.21% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -70.84% | -68.95% | -72.59% | -65.75% | -46.90% |
|
|||||
Total Accounts Payable | -94.43% | -56.75% | -69.69% | -48.35% | -27.64% |
Total Accrued Expenses | -80.31% | -70.04% | -55.79% | -58.37% | -66.87% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -24.04% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -87.13% | -71.55% | -66.46% | -58.92% | -59.29% |
|
|||||
Total Current Liabilities | -87.13% | -71.55% | -66.46% | -58.92% | -59.29% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -9.02% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -93.88% | -87.99% | -85.56% | -91.31% | -79.74% |
|
|||||
Common Stock & APIC | 0.04% | 0.20% | -2.29% | -2.18% | -2.20% |
Retained Earnings | -8.56% | -10.60% | -13.33% | 4.38% | 6.61% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -61.71% | -62.85% | -69.42% | 34.10% | 48.54% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -61.71% | -62.85% | -69.42% | 34.10% | 48.54% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -61.71% | -62.85% | -69.42% | 34.10% | 48.54% |
|